Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)

SMI Mahboubi Rabbani, A Zarghi - Expert opinion on therapeutic …, 2019 - Taylor & Francis
… , integrin has a well-established role in cancer cell signal transduction pathways where
antagonism of integrin activity is a potentially useful strategy of cancer treatment [Citation33]. …

[HTML][HTML] Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing

AA El-Malah, MM Gineinah, PK Deb, AN Khayyat… - Pharmaceuticals, 2022 - mdpi.com
… claimed lower potential of serious … treatment of corticosteroids, while the other (ie, COX-2)
is induced by the inflammatory stimuli or cytokines that can be inhibited by the administration of …

Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)

M Mahboubi-Rabbani, AH Abdolghaffari… - Expert Opinion on …, 2024 - Taylor & Francis
potential to greatly increase the effectiveness of chemotherapy. Our extensive understanding
of selective COX-2 inhibitor … the widespread administration of selective COX-2 inhibitors as …

[HTML][HTML] Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management

C Rawat, S Kukal, UR Dahiya, R Kukreti - Journal of neuroinflammation, 2019 - Springer
… In this article, we review the preclinical and clinical evidences supporting the role of COX-2
potential therapeutic use of COX-2 inhibitors as (1) anticonvulsants for epilepsy management

[HTML][HTML] COX-2 as a potential biomarker and therapeutic target in melanoma

DV Tudor, I Bâldea, M Lupu, T Kacso… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
… could be a suitable choice as adjuvants in the therapeutic management of … COX-2 inhibitors
efficacy used alone or as part of combination therapy in melanoma. COX-2 inhibitors tested …

[HTML][HTML] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement

S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
… In addition, such a combination can reduce toxicity and chemoresistance and enhance
radiosensitivity, although COX-2 inhibitors-related cardiotoxicity may potentially affect its use. …

New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation

EM Ahmed, MSA Hassan, AA El-Malah, AE Kassab - Bioorganic chemistry, 2020 - Elsevier
… towards COX-2 inhibition compared to indomethacin. Compounds 3d, 3g and 6a exhibited
significantly increased potency towards COX-2 … Furthermore, the selective COX-2 inhibitor 3g …

NSAIDs: Old acquaintance in the pipeline for cancer treatment and prevention─ Structural modulation, mechanisms of action, and bright future

S Ramos-Inza, AC Ruberte, C Sanmartin… - Journal of Medicinal …, 2021 - ACS Publications
COX-2 enzyme and production of immunosuppressive prostaglandin E2 (PGE2). This fact
confirmed COX-2 inhibition … the potential benefits of NSAIDs in the prevention and treatment of …

Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents

EM Ahmed, AE Kassab, AA El-Malah… - European Journal of …, 2019 - Elsevier
… common side-effects associated with the chronic administration of NSAIDs. Therefore, we
were interested in determining the ulcerogenic potential of the most potent compounds, 2d, 2f, …

[HTML][HTML] NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase

OR Kolawole, K Kashfi - International journal of molecular sciences, 2022 - mdpi.com
… trials with COX-2 inhibitors for cancer prevention or treatment. … and selective COX-2 inhibitors
(COXIBs) on targets beyond … Therefore, there is a potential role for NSAIDs via activation to …